Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Shares Issued (2016 - 2025)

Historic Shares Issued for BioRestorative Therapies (BRTX) over the last 13 years, with Q2 2025 value amounting to $927335.0.

  • BioRestorative Therapies' Shares Issued changed N/A to $927335.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year change of. This contributed to the annual value of $906000.0 for FY2024, which is 5113.24% down from last year.
  • Latest data reveals that BioRestorative Therapies reported Shares Issued of $927335.0 as of Q2 2025.
  • Over the past 5 years, BioRestorative Therapies' Shares Issued peaked at $7.5 million during Q1 2024, and registered a low of $927335.0 during Q2 2025.
  • Moreover, its 3-year median value for Shares Issued was $1.3 million (2023), whereas its average is $2.7 million.
  • The largest annual percentage gain for BioRestorative Therapies' Shares Issued in the last 5 years was 8560.16% (2025), contrasted with its biggest fall of 8560.16% (2025).
  • Over the past 3 years, BioRestorative Therapies' Shares Issued (Quarter) stood at $1.4 million in 2023, then soared by 421.95% to $7.5 million in 2024, then plummeted by 87.68% to $927335.0 in 2025.
  • Its Shares Issued stands at $927335.0 for Q2 2025, versus $1.1 million for Q1 2025 and $7.5 million for Q1 2024.